Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Afren 2011 Pretax Profit Surges - Quick Facts

3/27/2012 2:26 AM ET

Afren plc (AFR.L) Tuesday posted a sharply higher 2011 pretax profit of $221 million, compared to the prior-year's $79 million. Per-share earnings went up to 11.5 cents from 4.8 cents, with earnings from continuing operations of 11.9 cents per share in 2011 and 4.9 cents per share a year ago.

Revenue for the period was $596.7 million, rising from 2010's $319.4 million, reflecting start of production at the Ebok field. The company's 2011 revenues estimate, as of January 23, 2012, saw revenues of around $600 million.

Click here to receive FREE breaking news email alerts for Afren plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Gap Inc. Thursday after the markets closed that its first quarter profit rose 43% from last year, helped by higher sales and improved margins. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company eaffirmed its fiscal year 2013 earnings outlook, which is below analysts' current consensus estimate. After moving sharply lower at the start of trading on Thursday, stocks showed a substantial recovery attempt over the course of the trading day. The rebound came as upbeat housing data helped offset worries about the Federal Reserve. The major averages climbed well off their worst levels of the day but still ended the session in the red. President Barack Obama delivered a highly-anticipated speech on his administration's evolving counterterrorism policies on Thursday, suggesting that the U.S. needs to move away from a "boundless global war on terror." More than a decade after the 9/11 attacks, Obama argued that the terrorist threat has shifted and evolved.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.